Genomic Test Shows Promise as Predictor of Chemotherapy Response, Survival for Women with Invasive Breast Cancer A new genomic test combining multiple signatures – a patient’s estrogen receptor status, endocrine therapy response, chemotherapy resistance and sensitivity – shows promise as a predictor of chemotherapy response and survival benefit in women with invasive breast cancer. [Press release from The University of Texas MD Anderson Cancer Center discussing online prepublication in the Journal of the American Medical Association] Normal Stem Cells Made to Look and Act Like Cancer Stem Cells Researchers, after isolating normal stem cells that form the developing placenta, have given them the same properties of stem cells associated with an aggressive type of breast cancer. [Press release from the University of North Carolina at Chapel Hill School of Medicine discussing online prepublication in Cell Stem Cell] Coffee Consumption Modifies Risk of Breast Cancer In a new study a research group shows that drinking coffee may reduce the risk of estrogen receptor-negative breast cancer in women. [Press release from Karolinska Institutet discussing online prepublication in Breast Cancer Research] Parsley, Celery Carry Crucial Component for Fight Against Breast Cancer, Researcher Finds In a new study, a researcher has found that a compound in parsley and other plant products, including fruits and nuts, can stop certain breast cancer tumor cells from multiplying and growing. [Press release from the University of Missouri discussing online prepublication in Cancer Prevention Research] Strong Evidence Supports Prognostic Value of Circulating Tumor Cells in Breast Cancer Researchers have reported the strongest proof yet that evidence of ‘circulating tumor cells’ found in samples of a patient’s blood is strongly linked to poor outcomes such as a short time to disease progression. [Press release from the European Society for Medical Oncology discussing research presented at the IMPAKT Breast Cancer Conference] Epigenetic Study Reveals New Insights into Breast Cancer The most comprehensive analysis yet of the epigenetic modifications present in breast cancer has revealed potentially important new ways to detect and treat the disease, researchers have reported. [Press release from the European Society for Medical Oncology discussing research presented at the IMPAKT Breast Cancer Conference] Gene Expression Predicts Chemotherapy Sensitivity of Triple-Negative Breast Cancer Researchers have identified an unexpected molecular marker that predicts how sensitive hard-to-treat triple-negative breast cancers are to chemotherapy. [Press release from the European Society for Medical Oncology discussing research presented at the IMPAKT Breast Cancer Conference] Breast Cancer Multi-Gene Tests Compared Two multi-gene tests designed to predict the risk of disease progression and response to chemotherapy in breast cancer produce broadly similar results for high- and low-risk patients, but do not always agree in their predictions for those at intermediate risk, a new analysis shows. [Press release from the European Society for Medical Oncology discussing research presented at the IMPAKT Breast Cancer Conference] Protein Snapshots Reveal Clues to Breast Cancer Outcomes Measuring the transfer of tiny amounts of energy from one protein to another on breast cancer cells has given scientists a detailed view of molecular interactions that could help predict how breast cancer patients will respond to particular therapies. [Press release from the European Society for Medical Oncology discussing research presented at the IMPAKT Breast Cancer Conference] Anti-Inflammatory Drug May Fight Breast Cancer The anti-inflammatory drug celecoxib may be a useful additional treatment for people with breast cancer, researchers report. [Press release from the European Society for Medical Oncology discussing research presented at the IMPAKT Breast Cancer Conference] |